Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott R. Greer Insider Profile
11 Followers
Scott R. Greer, Director at Nektar Therapeutics, holds 303.57K shares in Nektar Therapeutics (Ticker: NKTR), holds 60.48K shares in Inogen (Ticker: INGN), holds 58.77K shares in Sientra (Ticker: SIENQ).
Profitable Transactions
4 out of 10 Profitable Transactions
Average Return
-13.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott R. Greer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 25, 2016 - Oct 25, 2017
Return:+89.10%
The most profitable trade made by Scott R. Greer
Scott R. Greer's Trading History
Nektar Therapeutics
Sep 20, 2022
Director
Uninformative Buy
―
$431.08K
Inogen
May 12, 2021
Director
Uninformative Buy
―
$417.30K
Aravive
Dec 22, 2017
―
Uninformative Buy
―
$1.78K
Microbot Medical
Jan 05, 2016
Director
Uninformative Buy
―
$255.07K
Auspex Pharma
May 05, 2015
―
Uninformative Sell
―
―
Sientra
Jun 07, 2018
Director
Uninformative Buy
125.01K
$4.47K
List of latest transactions for each holding click on a transaction to see Scott R. Greer's performance on stock
You May Also Like
Scott R. Greer insider profile FAQ
What is the percentage of profitable transactions made by Scott R. Greer?
The percentage of profitable transactions made by Scott R. Greer is 40%.
What is the average return per transaction made by Scott R. Greer?
The average return per transaction made by Scott R. Greer is -13.00%.
What stocks does Scott R. Greer hold?
Scott R. Greer holds: NKTR, INGN, ARAV, MBOT, ASPX, SIENQ stocks.
What was Scott R. Greer’s latest transaction?
Scott R. Greer latest transaction was an Uninformative Buy of ―.
What was Scott R. Greer's most profitable transaction?
Scott R. Greer’s most profitable transaction was an Informative Buy of NKTR stock on October 25, 2016. The return on the trade was 89.10%.
What is Scott R. Greer's role in Nektar Therapeutics?
Scott R. Greer's role in Nektar Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.